Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 000220218 approvals29 trials

Yuyu Pharma, Inc.

Official website

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

As of 2026-10-10, Yuyu Pharma, Inc. has 23 Korean MFDS device approvals, 195 Korean MFDS drug approvals, 5 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1941 as Yuhan Trading Co. and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company. It manufactures and sells prescription drugs and health functional foods, and it signed a co-promotion and distribution agreement with Dong-A ST for Tanamin (April 2024-March 2029, total contract value KRW 121.56 billion). It is developing the improved new drugs YY-DUT (a single-agent dutasteride formulation, research started 2019) and YY-DUT-Tam (a dutasteride-tamsulosin combination, research started 2022) for benign prostatic hyperplasia, both preparing for bioequivalence trials in the US and Europe, in a market Global Data sized at USD 4.5 billion worldwide in 2024.

Products & technology

  • TanaminCo-promotion and distribution item with Dong-A ST

Regulatory approvals

data.go.kr

195 Korean MFDS drug approvals · 1979–2026 / 23 Korean MFDS device approvals · 2004–2018

  • MFDS drugYumisil Tab. 250mg2026-05-07
    Drug · Prescription · Approval202601346
  • MFDS drugCozal Pro Nasal Spray Solution2025-12-29
    Drug · OTC · Notification202503408
  • MFDS drugYumisil Nail Lacquer (Terbinafine hydrochloride)2025-12-24
    Drug · OTC · Approval202503373
  • MFDS drugCozal Kids Nasal Spray Solution 0.05%(Xylometazoline Hydrochloride)2025-11-27
    Drug · OTC · Notification202503103
  • MFDS drugCozal Power Nasal Spray Solution 0.1%(Xylometazoline Hydrochloride)2025-11-26
    Drug · OTC · Notification202503084
  • MFDS drugAlfaky soft capsule 0.25mcg(Alfacalcidol)2025-08-08
    Drug · OTC · Approval202502063
  • MFDS drugAlfaky soft capsule 0.5mcg(Alfacalcidol)2025-07-28
    Drug · OTC · Notification202501947
  • MFDS drugAlfaky soft capsule 1mcg(Alfacalcidol)2025-07-28
    Drug · OTC · Notification202501948
  • MFDS drugFexoone Tab. 60mg (Fexofenadine Hydrochloride)2025-01-07
    Drug · Prescription · Approval202500054
  • MFDS drugFexogien Tab. 180mg (Fexofenadine Hydrochloride)2024-11-21
    Drug · Prescription · Approval202402752
  • MFDS drugSenuvela Tab. 400mg (Sevelamer carbonate)2024-10-10
    Drug · Prescription · Approval202402409
  • MFDS drugCozal S Nasal Spray Solution (Sodium chloride)2024-08-09
    Drug · OTC · Notification202401938
Show 68 more
  • MFDS drugMygran tablet 25mg(sumatriptansuccinate)2024-07-05
    Drug · Prescription · Approval202401652
  • MFDS drugpullisio Tab2024-05-20
    Drug · OTC · Notification202401210
  • MFDS drugAllestar Tab. 120mg(Fexofenadine Hydrochloride)2024-04-01
    Drug · OTC · Notification202400708
  • MFDS drugLasea soft capsule (Lavender oil)2024-02-07
    Drug · OTC · Approval202400293
  • MFDS drugFexogien Tab. 60mg (Fexofenadine Hydrochloride)2023-06-01
    Drug · OTC · Approval202301723
  • MFDS drugTanamin Tab. 240mg(Ginkgo Leaf Dried Ext.)2023-04-07
    Drug · OTC · Notification202301173
  • MFDS drugNewmacor s soft capsule 500mg(Omega-3-acid ester 90)2023-03-23
    Drug · Prescription · Approval202301017
  • MFDS drugSenuvela Tab(Sevelamer carbonate)2022-06-14
    Drug · Prescription · Approval202202489
  • MFDS drugNewxiga Tab. 10mg2022-05-24
    Drug · Prescription · Approval202202198
  • MFDS drugDsplus Tab 10/100mg2022-01-28
    Drug · Prescription · Approval202200496
  • MFDS drugNagran ODT 2.5mg (Naratriptan Hydrochloride)2021-10-18
    Drug · Prescription · Approval202106983
  • MFDS drugYUVARO Tab 15mg(Rivaroxaban)2021-02-24
    Drug · Prescription · Approval202101863
  • MFDS drugYUVARO Tab 10mg(Rivaroxaban)2021-02-24
    Drug · Prescription · Approval202101864
  • MFDS drugYutozet Tab 10/40mg(Ezetimibe/Atorvastatin Calcium)2021-01-08
    Drug · Prescription · Approval202100192
  • MFDS drugYutozet Tab 10/10mg(Ezetimibe/Atorvastatin Calcium)2021-01-08
    Drug · Prescription · Approval202100193
  • MFDS drugYutozet Tab 10/20mg(Ezetimibe/Atorvastatin Calcium)2021-01-08
    Drug · Prescription · Approval202100194
  • MFDS drugRisestar Tab(Risedronate sodium/Cholecalciferol)Revoked2021-01-04
    Drug · Prescription · Approval202100011
  • MFDS drugNewmacor R Soft Cap(Omega-3-acid ethyl esters 90/Rosuvastatin Calcium)2020-12-01
    Drug · Prescription · Approval202008413
  • MFDS drugA-Plar Inj.(Paricalcitol)2020-11-26
    Drug · Prescription · Approval202008258
  • MFDS drugYuyu Barostop Plaster(Felbinac)Revoked2020-11-24
    Drug · OTC · Notification202008134
  • MFDS drugNootromin inj.(proteolytic peptide from porcine brain)2020-10-13
    Drug · Prescription · Notification202006964
  • MFDS drugYurovazet Tab.10/10mg(Ezetimibe /Rosuvastatin Calcium)2020-06-23
    Drug · Prescription · Approval202004557
  • MFDS drugYurovazet Tab.10/5mg(Ezetimibe /Rosuvastatin Calcium)2020-06-23
    Drug · Prescription · Approval202004558
  • MFDS drugYurovazet Tab.10/20mg(Ezetimibe /Rosuvastatin Calcium)2020-06-23
    Drug · Prescription · Approval202004559
  • MFDS drugBazesta mono Tab. 20mg (Bazedoxifene Acetate)Revoked2020-05-11
    Drug · Prescription · Approval202003381
  • MFDS drugYulect tab 0.5mg(Rasagiline Mesylate)2020-03-31
    Drug · Prescription · Approval202002217
  • MFDS drugYumarin Syrup(Pelargonium Sidoides 11% Ethanol Extract(1->8~10)∙Glycerin Mixed Solution(8:2)2020-02-10
    Drug · Prescription · Notification202000755
  • MFDS drugYumarin Tab.(Pelargonium Sidoides 11% Ethanol Extract(1->8~10))2020-02-05
    Drug · Prescription · Notification202000674
  • MFDS drugOhsole inj(Cholecalciferol)2020-01-29
    Drug · Prescription · Notification202000450
  • MFDS drugyuyuvenosmin Tab. 600mg(Diosmin)2020-01-21
    Drug · OTC · Notification202000337
  • MFDS drugYulect Tab. 1mg(Rasagiline Mesylate)2019-11-29
    Drug · Prescription · Approval201908165
  • MFDS drugyuramin syrup(Acetylcysteine/Chlorpheniramine)Revoked2019-10-31
    Drug · OTC · Notification201907610
  • MFDS drugyumapron patch10(rivastigmine)Revoked2019-10-08
    Drug · Prescription · Approval201907123
  • MFDS drugyumapron patch5(rivastigmine)Revoked2019-10-08
    Drug · Prescription · Approval201907124
  • MFDS drugYuglimepo Tab 15/850mg(pioglitazone hydrochloride, metformin hydrchloride)Revoked2019-09-19
    Drug · Prescription · Approval201906555
  • MFDS drugyuyucalcium polystyrene Sulfonate powder(polystyrene Sulfonat calcium)Revoked2019-09-09
    Drug · Prescription · Notification201906371
  • MFDS drugyuyuatorvastatin Calcium Trihydrate Tab 10mg(atorvastatin calcium trihydrate)Revoked2019-09-05
    Drug · Prescription · Approval201906316
  • MFDS drugyuyuatorvastatin Calcium Trihydrate Tab 20mg(atorvastatin calcium trihydrate)Revoked2019-09-05
    Drug · Prescription · Approval201906317
  • MFDS drugyuyu polystyrene Suspension Sol(polystyrene sulfonate calcium)Revoked2019-08-26
    Drug · Prescription · Notification201906064
  • MFDS drugyuyutami Suspension Powder 6mg/Ml(Oseltamivir phosphate)Revoked2019-07-04
    Drug · Prescription · Approval201904553
  • MFDS drugMonteluna Tab. 10mg(Montelukast sodium)Revoked2019-06-25
    Drug · Prescription · Approval201904353
  • MFDS drugyuyurisperidone Tab 1mg(risperidone)Revoked2019-06-25
    Drug · Prescription · Approval201904354
  • MFDS drugyuyurisperidone Tab 2mg(risperidone)Revoked2019-06-21
    Drug · Prescription · Approval201904292
  • MFDS drugYurostin Tab. 10mg(Rosuvastatin Calcium)Revoked2019-06-11
    Drug · Prescription · Approval201903811
  • MFDS drugyupogrel SR Tab. 300mg(Sarpogrelate HCl)Revoked2019-06-04
    Drug · Prescription · Approval201903729
  • MFDS drugyuyudoxycycline tab.(doxycycline monohydrate)Revoked2019-05-23
    Drug · Prescription · Approval201903364
  • MFDS drugyugli Tab. 15mg(pioglitazone hydrochloride)Revoked2019-05-22
    Drug · Prescription · Approval201903308
  • MFDS drugyumesartan tab. 20mg(olmesartan medoxomil)Revoked2019-05-20
    Drug · Prescription · Approval201903231
  • MFDS drugMotium Tab. 1mg(Prucalopride succinate)2019-04-24
    Drug · Prescription · Approval201902573
  • MFDS drugYuyu Acetrama Semi ER TabletRevoked2019-04-19
    Drug · Prescription · Approval201902451
  • MFDS drugYuyu Acetrama ER TabletRevoked2019-04-19
    Drug · Prescription · Approval201902452
  • MFDS drugyurazole Tab. 10mg(Rabeprazole sodium)Revoked2019-04-16
    Drug · Prescription · Approval201902328
  • MFDS drugYurazol tablet 20mg(Rabeprazole Sodium)Revoked2019-04-16
    Drug · Prescription · Approval201902329
  • MFDS drugUmapron Cap. 3mg(rivastigmin tartrate)Revoked2019-04-12
    Drug · Prescription · Approval201902270
  • MFDS drugUmapron Cap. 1.5mg(rivastigmin tartrate)Revoked2019-04-12
    Drug · Prescription · Approval201902271
  • MFDS drugEpinamin Tab. 20mg(Epinastine Hcl)Revoked2019-04-11
    Drug · Prescription · Approval201902214
  • MFDS drugTelmia Plus Tab. 80/5mg(Telmisartan/Amlodipine besylate)Revoked2019-04-08
    Drug · Prescription · Approval201902125
  • MFDS drugTelmia Plus Tab. 40/10mg(Telmisartan/Amlodipine besylate)Revoked2019-04-08
    Drug · Prescription · Approval201902126
  • MFDS drugTelmia Plus Tab. 40/5mg(Telmisartan/Amlodipine besylate)Revoked2019-04-08
    Drug · Prescription · Approval201902127
  • MFDS drugEzenti Tab. 10mg(Ezetimibe)Revoked2019-04-08
    Drug · Prescription · Approval201902131
  • MFDS drugMotium Tab. 2mg(Prucalopride succinate)2019-03-28
    Drug · Prescription · Approval201901879
  • MFDS drugyuscon soft cap.(alverine citrate/simethicone)Revoked2019-03-27
    Drug · Prescription · Notification201901853
  • MFDS drugyucough Cap. 300mg(Theobromine)Revoked2019-03-27
    Drug · Prescription · Notification201901854
  • MFDS drugmygran tab. 50mg(sumatriptan succinate)2019-01-30
    Drug · Prescription · Notification201900721
  • MFDS drugBebeph tab.(Cinacalcet hydrochloride)2018-07-31
    Drug · Prescription · Approval201803170
  • MFDSHeating/cooling pad system control unitRevoked2018-07-17
    Product approval · Class 2수인 18-4494 호
  • MFDSHeating/cooling pad system control unitRevoked2018-07-17
    Product approval · Class 2수인 18-4493 호
  • MFDSanalyzer, BilirubinometryRevoked2018-06-08
    Product approval · Class 1체외 수신 18-1185 호

Showing the 80 most recent of 218 records.

Clinical trials

data.go.kr

29 MFDS clinical trial authorisations · 2014–2026 (Bioequivalence 23 · Phase 1 4 · Phase 1/2a 1 · Phase 3 1)

  • Phase 1YY-AC32026-09-04

    1 trial site

  • BioequivalenceYY-AC12025-11-27

    2 trial sites

  • BioequivalenceYY-AB92025-10-27

    2 trial sites

  • BioequivalenceYY-AB92025-10-27

    2 trial sites

  • BioequivalenceYY-AB22024-11-07

    1 trial site

  • BioequivalenceYY-AB82024-09-04

    1 trial site

  • BioequivalenceYY-10012024-03-20

    1 trial site

  • Bioequivalence유유펙소페나딘정180밀리그램(가칭)2023-05-24

    1 trial site

  • Bioequivalence유유사쿠비트릴발사르탄정200밀리그램(가칭)2021-10-15

    1 trial site

  • BioequivalenceYY두타스테리드정제(가칭) 0.5mg2020-02-13

    1 trial site

  • BioequivalenceYY아토젯(가칭) 10/40mg2019-10-31

    1 trial site

  • Phase 1/2aYY-1012019-03-12
Show 17 more
  • Bioequivalence유유나라트립탄구강붕해정2.5밀리그램2018-06-22

    2 trial sites

  • Bioequivalence유유라사길린정 1mg2018-04-10

    2 trial sites

  • Phase 1YY-1012018-03-21

    1 trial site

  • Phase 3YY-2012018-03-09

    1 trial site

  • Bioequivalence에소원정 40mg2017-10-25

    2 trial sites

  • Bioequivalence유유수마트립탄정 50mg2017-10-17

    2 trial sites

  • Bioequivalence유유프루칼로프라이드정 2mg(프루칼로프라이드숙신산염)2017-09-28

    2 trial sites

  • Bioequivalence유바로정 20mg (리바록사반)2017-06-30

    2 trial sites

  • Bioequivalence유픽사반5밀리그램(아픽사반)2017-05-29

    2 trial sites

  • Phase 1YY-2012017-02-07

    1 trial site

  • Bioequivalence유유나프토피딜정75밀리그램2016-08-02

    2 trial sites

  • Bioequivalence유리가트정80밀리그램(페북소스타트)2016-06-27

    2 trial sites

  • Phase 1아보다트연질캡슐0.5mg(200409982)+시알리스정5mg(200807091)2016-04-15

    1 trial site

  • Bioequivalence두스타연질캡슐 0.5밀리그램(두타스테리드)2016-01-13

    2 trial sites

  • Bioequivalence프로스연질캡슐0.5밀리그램(두타스테리드)2015-05-20

    2 trial sites

  • Bioequivalence본키연질캡슐(칼시트리올)2014-03-25

    2 trial sites

  • Bioequivalence유유오메가-3 연질캡슐2014-01-06

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

YY-DUT · 전립선비대증 · 생물학적동등성시험 준비중(미국, 유럽) · A dutasteride (0.5mg) improved new drug acting via 5-alpha reductase inhibition, research started in 2019, with a size reduced to one-third of the original for easier dosing. Competes with Avodart; market size was USD 4.5 billion worldwide in 2024.

YY-DUT-Tam · 전립선비대증 · 생물학적동등성시험 준비중(미국, 유럽) · A dutasteride (0.5mg) and tamsulosin (0.4mg) combination drug, research started in 2022, with dual mechanisms of 5-alpha reductase inhibition and selective alpha1A-adrenergic receptor antagonism. Competes with Jalyn soft capsules; market size was USD 4.5 billion worldwide in 2024.

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 64 more patents

AI reads

MAA server logs · IP-verified
228
Times AI engines pulled Yuyu Pharma, Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

227
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

11
live 1
Last 7 days
182
live 1
Last 30 days
228
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot186
  • GoogleGoogleOther33
  • PerplexityPerplexityBot6
  • AnthropicClaudeBot2

Measured since Aug 26, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Yuyu Pharma, Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Autech Corporation8 shared

Founded in 1991 and KOSDAQ-listed in 2003, Autech Corporation manufactures specialty vehicles such as ambulances and refrigerated trucks.

MEDIANA Co.,LTD5 shared

Founded in 1995 and listed on KOSDAQ in 2014, Mediana is a hospital medical device maker developing and manufacturing patient monitors and automated external defibrillators under its own brand and via ODM.

SEWOONMEDICAL CO,. LTD.3 shared

Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.

MEKICS Co., Ltd2 shared

KOSDAQ-listed critical-care medical device company manufacturing ventilators, the OmniOx respiratory therapy device series, and patient monitors.

Boryung Corporation2 shared

Founded in 1963 and listed in 1988, Boryung is a pharmaceutical and CDMO firm built around its antihypertensive drug Kanarb.

SEERS Co., Ltd.2 shared

Founded in 2009, SEERS provides the wearable ECG analysis solution mobiCARE and the inpatient monitoring solution thynC, based on AI vital-sign analytics.

Alpha AI Co.,Ltd.2 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

T&L Co., LTD.2 shared

Established in 1998 and listed on KOSDAQ in 2020, T&L manufactures wound dressings, microneedles, and orthopedic fixation products.

BNC KOREA, Inc.2 shared

Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.

DONG-A ST CO.,LTD2 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

SCL Science Inc.1 shared

Founded in 2010 and KOSDAQ-listed in 2019, SCL Science operates medical sealant, bio-logistics, and data platform businesses.

BTB Korea Co.,Ltd1 shared

KOSDAQ-listed aesthetic medical device company producing PICO, DUAL HI, and other anti-aging and body-contouring devices.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition